TCosmetic Procedures Down 12% in 2008
Americans cut back on plastic surgery and other cosmetic procedures last year, according to the American Society for Aesthetic Plastic Surgery (ASAPS).The ASAPS today released its 2008 statistics, which show a decrease of 12% in the number of surgical and nonsurgical cosmetic procedures performed in the U.S. last year....
[read article]

New Botulinum Toxin May Be Effective, Well Tolerated for Wrinkles
C botulinum type A toxin–hemagglutinin complex A (Reloxin, Medicis Pharmaceutical Corp) appears to be well tolerated and may help improve and maintain the appearance of moderate to severe forehead wrinkles for 13 months, according to the results of a phase 3, open-label study reported in the March issue of the Archives of Facial Plastic Surgery. The study investigators were Ronald Moy, MD, from Moy-Fincher Medical Group in Los Angeles....
[read article]

Retinoblastoma Survivors Often Die From Other Malignancies
Survivors of hereditary retinoblastoma are 35 times more likely to die from cancer than are people in the general population, according to a report in the Journal of the National Cancer Institute for April 15. For survivors of non-hereditary retinoblastoma, the risk is increased 2.5-fold....
[read article]

Tadalafil or Sildenafil Not Linked to Visual Effects With 6 Months of Daily Use
Daily administration of the phosphodiesterase type 5 (PDE5) inhibitors tadalafil or sildenafil for 6 months for erectile dysfunction (ED) was not associated with any abnormalities in electroretinography (ERG) or visual function or with any treatment-related findings suggestive of drug toxicity, according to the results of a randomized controlled trial reported in the April issue of the Archives of Ophthalmology....
[read article]

Glitazones May Raise Risk of Diabetic Macular Edema
Diabetics who use drugs from the glitazone class appear to have a modest increase in risk of developing macular edema, according to study findings in the American Journal of Ophthalmology for April....
[read article]

Gold Shunt Controls Pressure With Glaucoma
Implantation of a tiny gold-containing shunt into the supraciliary space is a safe and effective means of controlling intraocular pressures in patients with glaucoma, the results of pilot study suggest ...
[read article]

Institute of Medicine Recommends More Sleep, Fewer Work Hours for Residents
A new report by the Institute of Medicine (IOM) recommends strategies to reduce medical resident fatigue-related errors and improve patient safety and medical training by reducing residents' duty hours, increasing their sleep hours, ...
[read article]

Atropine and Patching Both Effective for Amblyopia in Older Children
Atropine eyedrops and patching are similarly effective in improving amblyopia among children aged 7 to 12 years, according to study results published in the December issue of the Archives of Ophthalmology ...
[read article]

Acute Accommodation Loss Benign in Young Patients
An isolated transient loss of accommodation unrelated to any other ocular or systemic disease may occur in young patients, a report from Israel concludes. However, vision appears to return to normal within weeks or months)...
[read article]

FDA Approves Allergan's Drug for Longer Eyelashes
Allergan Inc, maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse.Latisse is designed to treat ...
[read article]

Statins May Cause Rare Instances of Eye Muscle Disorders
Results of a study published in the December issue of Ophthalmology suggest that diplopia, ptosis, and ophthalmoplegia are associated with statin therapy at normal doses ...
[read article]

No Link Between Eye Cancer and Cell-Phone Use
There is no association between uveal melanoma, a rare form of eye cancer, and regular use of cell phones, says a group of German researchers who previously reported that there was an increased risk..
[read article]

FDA Not Effectively Monitoring Investigator Conflicts of Interest
More than one third of new drug marketing applications approved by the US Food and Drug Administration (FDA) were missing information about potential conflicts of interest for clinical trial investigators, which could allow bias to creep into the approvals process...
[read article]

Ranibizumab Improves Vision-Related Function in Wet AMD
In a randomized controlled trial, older patients with neovascular age-related macular degeneration (AMD) who received ranibizumab were more likely to report meaningful improvements in visual function compared with their counterparts who were treated with verteporfin photodynamic therapy....
[read article]

Where Are We After Twenty Years Of Cornea Research
Twenty years ago corneal research and treatments looked very different. Contact lens or glasses were the norm and LASIK was only a dream. Large refractive errors were actually treated by using a procedure that froze, lathed and then sutured a piece of ...
[read article]